Skip to main content
23andMe Holding Co. (ME)
NASDAQ: ME · IEX Real-Time Price · USD
0.392
+0.016 (4.15%)
At close: Jul 2, 2024, 4:00 PM
0.390
-0.002 (-0.38%)
After-hours: Jul 2, 2024, 7:56 PM EDT

23andMe Holding Co. Revenue

In the fiscal year ending March 31, 2024, 23andMe Holding Co. had annual revenue of $219.64M, a decrease of -26.66%. Revenue in the quarter ending March 31, 2024 was $64.03M, a -30.69% decrease year-over-year.

Revenue (ttm)
$219.64M
Revenue Growth
-26.66%
P/S Ratio
0.87
Revenue / Employee
$392,211
Employees
560
Market Cap
192.08M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 2024219.64M-79.85M-26.66%
Mar 31, 2023299.49M27.60M10.15%
Mar 31, 2022271.89M27.97M11.47%
Mar 31, 2021243.92M-61.54M-20.15%
Mar 31, 2020305.46M-135.44M-30.72%
Mar 31, 2019440.90M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Inogen 321.52M
Coherus BioSciences 301.87M
OptimizeRx 78.21M
Butterfly Network 68.08M
bluebird bio 21.73M
Lineage Cell Therapeutics 8.00M
Revenue Rankings

ME News

More News